• 
• 
• About Us
  • Epistem Biomarker Division
  • Epistem Plc
• 
• Technology
  • Technology
• 
• Applications
  • Biomarker Discovery and Assay Development
  • Preclinical Applications
  • Clinical Applications
  • Drug Response and Predictive Drug Response
  • Patient Stratification
  • Companion Biomarkers for Drug Development Programs
  • Efficacy and Treatment Monitoring
• 
• Investor
  • Investor Information
• 
• Contact
  • Contact
  • Request For Further Details
  • Request for Literature
  • Request for a Quotation

Applications

Companion Biomarkers for Drug Development Programs

Epistem’s biomarker core capabilities using our proprietary gene expression platform GenetRx™ cover the full drug development cycle from discovery through to commercialization, including:

• Protocol instructions for sample collection
• Instructions for plucking hair in clinical trials
• Identification of drug gene sets
• Compliance with GCLP
• Clinical deployment
• Clinical assessment and bioinformatic analysis
• Clinical validation
• Drug effect and treatment monitoring